The Saudi Food and Drug Authority (SFDA) has granted conditional approval for Anktiva, a groundbreaking cancer therapy, for ...

ImmunityBio, Inc. (NASDAQ:IBRX) is one of the best penny stocks to buy for 2026. On December 16, ImmunityBio, Inc.

Urology departments in England and Wales have reported seeing an increase in the number of 16- to 24-year-olds being admitted ...

The American Cancer Society estimates that over 80,000 individuals will be diagnosed with bladder cancer this year.

The Saudi Food and Drug Authority (SFDA) has granted conditional approval for Anktiva (nogapendekin alfa inbakicept) in ...

The QUILT-2.005 trial is a randomized registrational study designed to evaluate the effectiveness of ANKTIVA® combined with BCG in BCG-naïve patients. As of January 2026, enrollment has surpassed 85%, ...

The use of ketamine is rising among 16- to 24-year-olds in England and Wales, leading to increased bladder issues. The drug ...

Urology departments in England and Wales have seen an increase in bladder inflammation among 16 to 24-year-olds ...

Ketamine users can develop tolerance to the drug quickly, needing higher doses to get the same effects. This is probably due to the body and brain adapting to become more efficient at breaking down ...

Boston Scientific acquires Valencia Technologies' eCoin bladder dysfunction device, expanding into the $30M+ overactive ...

The collaborative clinical study will evaluate ADSTILADRIN® (nadofaragene firadenovec-vncg) in combination with the ...

Man patients with MIBC are ineligible for or refuse SOC cisplatin. SunRISe-4 evaluated neoadjuvant gemcitabine intravesical system (TAR-200) plus cetrelimab or cetrelimab monotherapy for pathologic ...